15 research outputs found
A consensus parameter for the evaluation and management of angioedema in the emergency department
Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioedema from one another and more specifically differentiate histaminergic-mediated angioedema from bradykinin-mediated angioedema, especially in lieu of the more novel treatments that have recently become available for bradykinin-mediated angioedema. With this background in mind, this consensus parameter for the evaluation and management of angioedema attempts to provide a working framework for emergency physicians (EPs) in approaching the patient with angioedema in terms of diagnosis and management in the ED. This consensus parameter was developed from a collaborative effort among a group of EPs and leading allergists with expertise in angioedema. After rigorous debate, review of the literature, and expert opinion, the following consensus guideline document was created. The document has been endorsed by the American College of Allergy, Asthma & Immunology (ACAAI) and the Society for Academic Emergency Medicine (SAEM)
Development And Validation Of The Angiotensin-Converting Enzyme Inhibitor (Acei) Induced Angioedema Investigator Rating Scale And Proposed Discharge Criteria
Prognostic value of Nâterminal proâBâtype natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis
OBJECTIVE: To evaluate the prognostic value of Nâterminal proâBâtype natriuretic peptide (NTâproBNP) in patients with aortic stenosis being treated conservatively or undergoing aortic valve replacement (AVR). METHODS: 159 patients were followed up for a median of 902 days. 102 patients underwent AVR and 57 were treated conservatively. NTâproBNP at baseline was raised in association with the degree of severity and of functional status. RESULTS: During follow up 21 patients (13%) died of cardiac causes or required rehospitalisation for decompensated heart failure. NTâproBNP at baseline was higher in patients with an adverse outcome than in eventâfree survivors (median 623 (interquartile range 204â1854)â
pg/ml v 1054 (687â2960)â
pg/ml, pâ
â=ââ
0.028). This difference was even more obvious in conservatively treated patients (331 (129â881)â
pg/ml v 1102 (796â2960)â
pg/ml, pâ
â=ââ
0.002). Baseline NTâproBNP independently predicted an adverse outcome in the entire study group and in particular in conservatively treated patients (area under the curve (AUC)â
â=ââ
0.65, pâ
â=ââ
0.028 and AUCâ
â=ââ
0.82, pâ
â=ââ
0.002, respectively) but not in patients undergoing AVR (AUCâ
â=ââ0.544). At a cutâoff value of 640â
pg/ml, baseline NTâproBNP was discriminative for an adverse outcome. CONCLUSION: NTâproBNP concentration is related to severity of aortic stenosis and provides independent prognostic information for an adverse outcome. However, this predictive value is limited to conservatively treated patients. Thus, the data suggest that assessing NTâproBNP may have incremental value for selecting the optimal timing of valve replacement
Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro
Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
A consensus parameter for the evaluation and management of angioedema in the emergency department - Un parĂĄmetro de consenso para la evaluaciĂłn y tratamiento del angioedema en el servicio de urgencias.
Recommended from our members
A Consensus Parameter for the Evaluation and Management of Angioedema in the Emergency Department
Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioedema from one another and more specifically differentiate histaminergic-mediated angioedema from bradykinin-mediated angioedema, especially in lieu of the more novel treatments that have recently become available for bradykinin-mediated angioedema. With this background in mind, this consensus parameter for the evaluation and management of angioedema attempts to provide a working framework for emergency physicians (EPs) in approaching the patient with angioedema in terms of diagnosis and management in the ED. This consensus parameter was developed from a collaborative effort among a group of EPs and leading allergists with expertise in angioedema. After rigorous debate, review of the literature, and expert opinion, the following consensus guideline document was created. The document has been endorsed by the American College of Allergy, Asthma & Immunology (ACAAI) and the Society for Academic Emergency Medicine (SAEM)